Search
for

    Sort by

    Research 30 of 1000+

    1. Trazodone by epigenetic mechanism can reverse the post finasteride syndrome Magna Scientia Advanced Research and Reviews · 2023
    2. Trazodone and chlorpromazine a proposal treatment for syndrome post-finasteride and syndrome of post-selective serotonin reuptake inhibitors (post-SSRI) Zenodo (CERN European Organization for Nuclear Research) · 2023
    3. 증례 : 순환기 ; 독사조신 복용 후 발생한 여성형유방증 1예 The Korean Journal of Internal Medicine · 2016
    4. Is sulfonamide group of tamsulosin main factor in the pathophysiology of floppy iris syndrome? Haydarpaşa Numune Hastanesi tıp dergisi · 2018
    5. Most recent findings of curative drugs for lower urinary tract symptoms in clinical practice Nihon Yakuri Gakkai nenkai yoshishu · 2019
    6. Inhibitors of 5α-Reductase in the Treatment of Benign Prostatic Hyperplasia Current pharmaceutical design · 2006 · 52 citations
    7. BPH: costs and treatment outcomes. PubMed · 2006 · 34 citations
    8. Pharmacophore Modeling and Three Dimensional Database Searching for Drug Design Using Catalyst: Recent Advances Current Medicinal Chemistry · 2004 · 153 citations
    9. Intraoperative floppy iris syndrome Current Opinion in Ophthalmology · 2008 · 41 citations
    10. Risk factors for intraoperative floppy iris syndrome: One year prospective study Acta Ophthalmologica · 2013
    11. BPH: epidemiology and comorbidities. PubMed · 2006 · 386 citations
    12. A Case of Gynecomastia Induced by Use of Doxazosin Korean Journal of Medicine · 2016
    13. A Comparison of Varying alpha-Blockers and Other Pharmacotherapy Options for Lower Urinary Tract Symptoms. PubMed · 2005 · 52 citations
    14. Pharmacological Approaches in Managing Symptomatic Relief of Benign Prostatic Hyperplasia: A Comprehensive Review Curēus · 2023 · 1 citations
    15. Efficacy and Side Effects of Drugs Commonly Used for the Treatment of Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia Frontiers in Pharmacology · 2020 · 35 citations
    16. Non-surgical management of BPH: An updated review of current literature and state of the art on natural compounds and medical therapy Archivio Italiano di Urologia e Andrologia · 2024 · 5 citations
    17. Trends in the Development of New Drugs for Treatment of Benign Prostatic Hyperplasia Current Medicinal Chemistry · 2006 · 14 citations
    18. 556 α 1 -AR agonist induced piloerection protects against the development of traction alopecia Journal of Investigative Dermatology · 2016
    19. Development of a Doxazosin and Finasteride Transdermal System for Combination Therapy of Benign Prostatic Hyperplasia Journal of pharmaceutical sciences · 2013 · 13 citations
    20. Current treatment of BPH Biomedicine & pharmacotherapy · 1995 · 11 citations
    21. Reversible exacerbation of obstructive sleep apnea by α1-adrenergic blockade with tamsulosin: A case report Respiratory Medicine Case Reports · 2016 · 3 citations
    22. Efficacy and safety of α-blockers plus 5α-reductase inhibitors for benign prostatic hyperplasia: a systematic review and meta-analysis European journal of medical research · 2026
    23. Intraoperative Floppy Iris Syndrome: Updated Perspectives Clinical Ophthalmology · 2020 · 28 citations
    24. Floppy Iris Syndrome Essentials in ophthalmology · 2022
    25. Direct Vasodilators and Sympatholytic Agents Journal of cardiovascular pharmacology and therapeutics · 2015 · 34 citations
    26. 5-Alpha-Reductase Inhibitors and Combination Therapy Urologic Clinics of North America · 2016 · 15 citations
    27. Incomplete Recovery of Erectile Function in Rat after Discontinuation of Dual 5‐Alpha Reductase Inhibitor Therapy The Journal of Sexual Medicine · 2012 · 29 citations
    28. Impact of Alpha Blockers, 5-alpha Reductase Inhibitors and Combination Therapy on Sexual Function Current Urology Reports · 2014 · 11 citations
    29. Analysis of Data From Breast Diseases Treated With 5-Alpha Reductase Inhibitors for Benign Prostatic Hyperplasia Clinical Breast Cancer · 2019 · 1 citations
    30. Efficacy and safety of 5 alpha-reductase inhibitor monotherapy in patients with benign prostatic hyperplasia: A meta-analysis PLOS ONE · 2018 · 19 citations